Publication | Open Access
Results of the TAPPAS trial: An adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS)
19
Citations
0
References
2019
Year
OncologyAdvanced AngiosarcomaMetronomic TherapyPathologyTappas TrialVersus PazopanibMedicineCancer Research
No additional data available for this publication yet. Check back later!